User profiles for Michael Orth

Michael Orth

- Verified email at uni-ulm.de - Cited by 10595

Michael Orth

- Verified email at uwrf.edu - Cited by 3919

Emerging competency methods for the future

TR Athey, MS Orth - … : Published in Cooperation with the School …, 1999 - Wiley Online Library
Competency‐based applications have gained a foothold in HR practice worldwide; however,
changes in the business environment and the structure of work itself are challenging the …

[PDF][PDF] Identification of genetic factors that modify clinical onset of Huntington's disease

…, P Holmans, L Jones, S Kwak, M Mahmoudi, M Orth… - Cell, 2015 - cell.com
As a Mendelian neurodegenerative disorder, the genetic risk of Huntington's disease (HD)
is conferred entirely by an HTT CAG repeat expansion whose length is the primary …

[HTML][HTML] Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

M Orth, P Metzger, S Gerum, J Mayerle, G Schneider… - Radiation …, 2019 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor prognosis
and rising incidence. Late detection and a particularly aggressive biology are the major …

[PDF][PDF] CAG repeat not polyglutamine length determines timing of Huntington's disease onset

…, M Ciosi, A Maxwell, A Chatzi, DG Monckton, M Orth… - Cell, 2019 - cell.com
Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted
HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, …

[HTML][HTML] Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants

PS Chan, JP Caron, GJM Rosa, MW Orth - Osteoarthritis and cartilage, 2005 - Elsevier
OBJECTIVE: Glucosamine (GLN) and chondroitin sulfate (CS) are widely used to alleviate
symptoms of osteoarthritis (OA). However, the mechanism(s) of action of these nutraceuticals …

Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice

S Botolin, MC Faugere, H Malluche, M Orth… - …, 2005 - academic.oup.com
Decreased bone mass, osteoporosis, and increased fracture rates are common skeletal
complications in patients with insulin-dependent diabetes mellitus (IDDM; type I diabetes). IDDM …

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)

…, MR van Walsem, RC van der Mast, M Orth… - Journal of Neurology …, 2014 - jnnp.bmj.com
Background The majority of Huntington's disease (HD) mutation carriers experience some
psychopathology during their lifetime, varying from irritability to psychosis, but prevalences of …

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

…, D Monza, L Mütze, M Oehmen, M Orth… - The Lancet …, 2017 - thelancet.com
Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin
gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis …

Observing Huntington's disease: the European Huntington's disease network's REGISTRY

M Orth… - Journal of Neurology …, 2011 - jnnp.bmj.com
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by
a CAG repeat expansion in the HTT gene. HD usually manifests in adult life, causing motor …

Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence

DJ Serrien, M Orth, AH Evans, AJ Lees, P Brown - Brain, 2005 - academic.oup.com
There is considerable evidence that Gilles de la Tourette syndrome (TS) is due to frontal–striatal
dysfunction. Here we determine whether adaptive cortical changes occur that might …